BI drug gets orphan status for MDS

10th March 2017 Uncategorised 0

Boehringer Ingelheim has bagged US orphan drug designation for its anti-CD33 monoclonal antibody BI 836858 for the treatment of myelodysplastic syndromes (MDS).

More: BI drug gets orphan status for MDS
Source: News